Drug · DIN 02492156
HYRIMOZ
PEN
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since February 15, 2021; first marketed February 15, 2021.
- Drug Identification Number (DIN)
- 02492156
- Company (DIN owner)
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Schedule
- Schedule d; Prescription
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Adalimumab L04AB04
- Class
- Human
- Record last updated
- August 17, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ADALIMUMAB | 40 MG | 0.8 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 4, 2020: NOC 24564New Drug Submission (NDS)
Other DINs named HYRIMOZ
- DIN 02492164 · Marketed
- DIN 02505258 · Marketed
- DIN 02542315 · Marketed
- DIN 02542323 · Marketed
- DIN 02542331 · Marketed
- DIN 02542358 · Marketed
- DIN 02542366 · Marketed